TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development
admin
6 days ago
New York State
2 Views
PressBee – Appointment builds on CHF 10 million seed financing and Board leadership expansion BASEL, Switzerland, Jan. 29, 2026 /PRNewswire/ — TECregen, a biotechnol
